Performance Diagnosis of a Patent Foramen Ovale During Lung Transplantation Using Transesophageal Echocardiography
Not Applicable
Completed
- Conditions
- Lung Transplant; Complications
- Registration Number
- NCT04165161
- Lead Sponsor
- Hopital Foch
- Brief Summary
The investigators hypothesis is that an injection into the inferior vena cava associated with a provocation maneuver should allow to increase the incidence of FOP found by transesophageal echocardiography in a population of patients undergoing lung transplantation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- Aged 18 years old minimum
- Benefiting from a lung transplant
- Having an upper vena cava catheter and a lower vena cava catheter set up as part of the usual care
- Having signed a consent form
- Affiliated to a insurance scheme or beneficiary (excluding AME)
Exclusion Criteria
- Pregnant or lactating women
- Having a contraindication to the insertion of the esophageal ultrasound probe
- deprived of liberty or under guardianship
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Incidence of transatrial passage of contrast media 1 day after lung transplantation Incidence of transatrial passage of contrast media
- Secondary Outcome Measures
Name Time Method Size of PFO, existence of an atrial septal aneurysm 1 day after lung transplantation Number of postoperative days with mechanical ventilation 30 days after lung transplantation Mortality during the stay in the hospital 30 days after lung transplantation Mortality at the postoperative 30-day 30 days after lung transplantation Incidence of pulmonary graft dysfunction, incidence of stroke, incidence of myocardial ischemia 30 days after lung transplantation Mortality during the stay in the intensive care unit 30 days after lung transplantation
Trial Locations
- Locations (1)
Hopital Foch
🇫🇷Suresnes, France
Hopital Foch🇫🇷Suresnes, France